Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACER2 pseudogene 1 (ACER2P1) is a type of pseudogene, a DNA sequence resembling the ACER2 (Alkaline ceramidase 2) gene but lacking protein-coding ability or known biological function. Pseudogenes generally have no enzymatic activity, are not expressed as functional proteins, and do not serve as therapeutic drug targets. No evidence indicates clinical importance or utility as a molecular biomarker or target for drug development. If you intended to refer to the functional gene Alkaline ceramidase 2 (ACER2) (not the pseudogene), please clarify, as ACER2 is a biologically and clinically relevant enzyme involved in sphingolipid metabolism, with roles in cancer and other diseases. However, "ACER2 pseudogene 1" specifically denotes a non-functional genomic sequence and is not a valid drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACER2 pseudogene 1 (ACER2P1).